Storage Error at New York Hospital Leaves 500 Newborns Needing Repeat Hep B Vaccines
Up to 500 newborns at a New York medical facility may require repeat hepatitis B vaccinations following a hospital refrigeration error.
Officials at Albany Medical Center confirmed that infants received vaccine doses kept at improper temperatures inside a hospital storage refrigerator.
While state health authorities confirmed the compromised doses pose no immediate health threat, the temperature lapse may have rendered the shots ineffective.
State Health Department Uncovers Vaccine Storage Log Errors
Inspectors from the New York State Department of Health discovered the lapse while reviewing refrigeration logs ahead of a planned hospital visit.
Initial reporting by The Times Union revealed that staff stored the vaccines below the manufacturer's recommended temperature thresholds.
In response, Albany Medical Center dispatched formal letters to affected parents and paediatricians explaining that repeat doses may be required.
A hospital spokesperson confirmed the facility apologised to impacted families and implemented immediate refrigeration safeguards to prevent future occurrences.
Furthermore, state health regulators ordered Albany Medical Center to submit comprehensive corrective action plans and updated policy documentation.
Strict Standards Essential to Prevent Nonviable Doses
Hepatitis B vaccines require strict temperature monitoring throughout storage to maintain biological viability and protect patient health.
Public health guidelines from Immunize.org state that all hepatitis B formulations must remain stored between 2°C and 8°C (36°F and 46°F). Medical authorities strictly warn against freezing these preparations, as sub-zero exposure damages active protein structures and reduces potency.
Whether a dose exposed to improper storage temperatures remains valid depends on the conditions and duration of the exposure. Health departments and vaccine manufacturers assess each case to determine whether repeat vaccination is necessary.
Paediatricians are advised to re-administer non-live vaccine doses as soon as possible to ensure children develop adequate antibody protection.
Early Infant Immunisation Prevents Severe Long-Term Liver Disease
The universal hepatitis B birth-dose framework has protected American infants from viral transmission since its introduction in 1991.
The routine three-dose infant hepatitis B series has traditionally been given at birth, at one to two months, and at six to 18 months. Hepatitis B is a viral blood-borne infection that can lead to chronic liver disease, cirrhosis, and liver cancer in infected infants.
On 16 December 2025, the CDC adopted a recommendation for shared decision-making about the hepatitis B birth dose for infants born to mothers who test negative for the virus. Infants born to mothers who test positive, or whose status is unknown, were still recommended to receive the vaccine within 12 hours of birth.
Kaiser Family Foundation data show that approximately 90.1 per cent of New York children born in 2022 had received all three hepatitis B vaccine doses by the age of 35 months.
Health officials urge affected parents to contact their doctors immediately to arrange replacement shots and secure long-term immunity.
What You Need To Know About Hep B Vaccines
Health authorities recommend the immunisation series for all infants, unvaccinated adolescents, and adults facing higher exposure risks or underlying conditions. The standard course requires two or three doses administered over a two- to six-month period to establish complete protection.
The Hepatitis B vaccine has a strong safety record, and studies indicate that protection can last at least 30 years in healthy people vaccinated during infancy.
Most people experience no major side effects, with temporary soreness at the injection site remaining the most common reaction. If a person misses a scheduled dose, medical guidance advises taking the next shot as soon as possible without restarting the entire series.